Literature DB >> 11418361

Outbreak of Hepatitis B among injecting drug users in Denmark.

P B Christensen1, H B Krarup, H G Niesters, H Norder, O B Schaffalitzky de Muckadell, B Jeune, J Georgsen.   

Abstract

BACKGROUND: The incidence of hepatitis B is low in Denmark, but injecting drug users (IDUs) remains a high-risk group for this infection.
OBJECTIVES: The aim of the study was to describe a hepatitis B outbreak among IDUs by comparing existing registers. Additionally, we wanted to analyze the genetic variation of the hepatitis B virus involved in the outbreak. STUDY
DESIGN: In the County of Funen, registers of laboratory diagnosis, hospital records and reports from clinicians to the Medical Officer of Health (MOH) were compared between 1992 and 1998. HBsAg positive sera recovered from the epidemic were sequenced and compared to known HBV strains.
RESULTS: We identified 648 cases of hepatitis B of which 51% (332) were acute infections. The laboratory database identified 96% (319/332) of these, 45% (150/332) were admitted to hospital and 38% (127/332) were reported to public health. By capture-recapture analysis based on MOH reports and hospital records the estimated total number of acute cases were 334 (95% C.I. 283-385). We sequenced 75 HBsAg positive samples and identified two very similar strains of genotype D (serotype ayw3) among IDUs involved in the outbreak.
CONCLUSIONS: The current surveillance system did not detect the majority of acute hepatitis B cases in County of Funen. We suggest laboratory-based surveillance of hepatitis B to be implemented at a national level as this may identify new outbreaks faster and more complete than the current surveillance system.

Entities:  

Mesh:

Year:  2001        PMID: 11418361     DOI: 10.1016/s1386-6532(01)00175-5

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  5 in total

1.  Identifying a hepatitis B outbreak by molecular surveillance: a case study.

Authors:  N Fisker; N L T Carlsen; H J Kolmos; L Tønning-Sørensen; A Høst; P B Christensen
Journal:  BMJ       Date:  2006-02-11

2.  Cloning of HBsAg-encoded genes in different vectors and their expression in eukaryotic cells.

Authors:  Shan Qin; Hong Tang; Lian-San Zhao; Fang He; Yong Lin; Li Liu; Xiao-Mei He
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

3.  Acute hepatitis B in the era of immunisation: pitfalls in the identification of high risk patients.

Authors:  G Rosner; Y Lurie; L Blendis; Z Halpern; R Oren
Journal:  Postgrad Med J       Date:  2006-03       Impact factor: 2.401

Review 4.  Opioid epidemic and liver disease.

Authors:  Elizabeth C Verna; Aaron Schluger; Robert S Brown
Journal:  JHEP Rep       Date:  2019-07-09

5.  Hepatitis C prevalence in Denmark -an estimate based on multiple national registers.

Authors:  Peer Brehm Christensen; Gordon Hay; Peter Jepsen; Lars Haukali Omland; Søren Andreas Just; Henrik Bygum Krarup; Nina Weis; Niels Obel; Susan Cowan
Journal:  BMC Infect Dis       Date:  2012-08-06       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.